ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,953Medicare Part D Prescriptions Filled, Including Refills

Rank: 211 out of 1185

$470K Total Retail Price of All Prescriptions

Rank: 306 out of 1185

297 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 297 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 297 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,425 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
WARFARIN SODIUM 700 698 1 21
LEVOTHYROXINE SODIUM 474 470 2 3
HYDROCODONE-ACETAMINOPHEN 381 381 S3 3 2
NAMENDA 357 357 4 43
LISINOPRIL 328 298 5 4
MIRTAZAPINE 316 316 6 57
AMLODIPINE BESYLATE 314 311 7 1
OMEPRAZOLE 299 293 8 6
METOPROLOL TARTRATE 285 256 9 10
SERTRALINE HCL 247 247 10 25
FUROSEMIDE 244 236 11 8
DONEPEZIL HCL 236 236 12 32
CITALOPRAM HBR 176 176 13 22
METOPROLOL SUCCINATE 166 165 14 20
METFORMIN HCL 154 111 15 9
TRAMADOL HCL 110 107 16 16
DIVALPROEX SODIUM 107 97 17 96
KLOR-CON 10 103 103 18 118
CARVEDILOL 95 94 19 24
DIGOXIN 94 94 20 67
ATENOLOL 90 90 21 28
PAROXETINE HCL 89 75 22 73
LANTUS 88 66 23 66
ZOLPIDEM TARTRATE 85 76 24 15
DIOVAN 82 67 25 37
QUETIAPINE FUMARATE 74 74 26 93
TAMSULOSIN HCL 74 62 26 34
SIMVASTATIN 73 60 28 5
RANITIDINE HCL 72 72 29 17
ESCITALOPRAM OXALATE 71 71 30 79
ISOSORBIDE MONONITRATE ER 67 67 31 48
NOVOLOG FLEXPEN 66 63 32 157
CARBIDOPA-LEVODOPA 64 64 33 142
LEVETIRACETAM 61 40 34 131
FINASTERIDE 61 61 34 132
GABAPENTIN 60 60 36 13
CLOPIDOGREL 59 43 37 31
PANTOPRAZOLE SODIUM 57 57 38 58
FAMOTIDINE 57 54 38 69
LATANOPROST 55 55 40 274
HYDROCHLOROTHIAZIDE 55 24 40 12
PREDNISONE 54 54 42 33
OLANZAPINE 52 52 43 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.